Published in J Ophthalmic Vis Res on January 01, 2014
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Clin Perinatol (2014) 0.80
Genomics in the neonatal nursery: Focus on ROP. Semin Perinatol (2015) 0.78
Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure. Int J Retina Vitreous (2017) 0.75
ADVANCES IN UNDERSTANDING AND MANAGEMENT OF RETINOPATHY OF PREMATURITY. Surv Ophthalmol (2016) 0.75
Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease. PLoS One (2017) 0.75
Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol (1953) 10.53
Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med (2010) 6.86
Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol (1954) 5.98
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics (2000) 5.36
Oxygen saturation and outcomes in preterm infants. N Engl J Med (2013) 4.96
A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med (1992) 3.56
Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1991) 3.27
Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics (2003) 2.89
Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust (1951) 2.83
Childhood blindness. J AAPOS (1999) 2.75
Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA (2013) 2.73
Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol (1952) 2.70
The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics (2005) 2.65
Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol (1953) 2.64
PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics (1977) 2.47
Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol (1956) 2.15
Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS (2006) 1.84
Recent increase in mortality from hyaline membrane disease. J Pediatr (1960) 1.76
Neonatal pulse oximetry: accuracy and reliability. Pediatrics (1989) 1.53
The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci (1995) 1.52
NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr (2011) 1.52
Retrolental fibroplasia and oxygen therapy. J Am Med Assoc (1954) 1.40
Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol (2004) 1.39
Retrolental fibroplasia and related ocular diseases; classification, etiology, and prophylaxis. Am J Ophthalmol (1953) 1.29
Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed (2012) 1.27
The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol (2006) 1.27
A survey of delivery room resuscitation practices in the United States. Pediatrics (2006) 1.24
High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics (2010) 1.16
Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology (2010) 1.15
Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? Pediatrics (2008) 1.10
Retrolental fibroplasia; incidence in different localities in recent years and a correlation of the incidence with treatment given the infants. J Am Med Assoc (1949) 1.08
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin Sci (Lond) (2013) 1.05
Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996 2005): is the incidence increasing? Pediatrics (2008) 0.90
Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity. JAMA Ophthalmol (2013) 0.83
Setting up and improving retinopathy of prematurity programs: interaction of neonatology, nursing, and ophthalmology. Clin Perinatol (2013) 0.83
Mechanisms and management of retinopathy of prematurity. N Engl J Med (2013) 0.81
Impact of changing oxygenation policies on retinopathy of prematurity in a neonatal unit in Argentina. Br J Ophthalmol (2012) 0.79
Retrolental fibroplasia. J Pediatr (1946) 0.77